Error: Could not add to watchlist. X
+ Watchlist

Credit Suisse Lux Global Biotech Innovators Equity Fund

CR4A:GR
Berlin
339.14
EUR
1.41
0.42%
As of 3:30 AM EDT 7/27/2016
Open
335.28
Day Range
335.24 - 341.13
Previous Close
337.73
52Wk Range
273.79 - 485.63
1 Yr Return
-25.24%
YTD Return
-18.69%
Open
335.28
Day Range
335.24 - 341.13
Volume
60
Previous Close
337.73
52Wk Range
273.79 - 485.63
1 Yr Return
-30.02%
YTD Return
-18.69%
NAV (on -)
118.25
Total Assets (m USD) (on 07/25/2016)
172.404
Inception Date
11/06/2001
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
IRENE BEATRICE PUETTNER
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
2.19%
3 Mo Return
0.64%
3 Yr Return
17.53%
5 Yr Return
25.26%

Top Fund Holdings

Name Position Value % of Fund
44.00 k 12.75 m 7.15
117.28 k 12.37 m 6.94
130.48 k 11.36 m 6.37
67.00 k 10.58 m 5.94
23.00 k 9.18 m 5.15
140.00 k 8.46 m 4.75
52.75 k 7.96 m 4.46
85.44 k 7.66 m 4.30
90.00 k 7.60 m 4.26
70.00 k 6.52 m 3.66
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
Address
Credit Suisse AG
Kalanderplatz 1
8070 Zurich
Switzerland
Tel: +41 44 333 40 50
Phone
-